Table 1 Patient characteristics
ICH | AIS | |z| or chi | p-value | |
|---|---|---|---|---|
n | 74 | 149 | ||
Age (years) | 58.5 (51–65) | 62 (54.5–67) | 1.80 | 0.0710 |
Male sex | 51 (68.9%) | 101 (67.8%) | 0.03 | 0.8640 |
Height (cm) | 166 (159.8–170) | 165 (160–171) | 0.01 | 0.9886 |
Bodyweight (kg) | 61.1 (59.5–78.5) | 66 (58–76.1) | 0.31 | 0.7600 |
BMI (kg/m2) | 24.2 (21.8–26.9) | 24.5 (21.8–26.8) | 0.15 | 0.8843 |
SBP (mmHg) | 183.5 (162–209) | 157 (138–181) | 5.23 | < 0.0001 |
DBP (mmHg) | 111.5 (97.8–129) | 96 (82.5–111.5) | 5.09 | < 0.0001 |
Glucose (mmol/L) | 6.8 (5.7–8.4) | 6.5 (5.8–8.3) | 0.03 | 0.9789 |
HbA1c (%) (NGSP) | 5.7 (5.5–6.15) | 5.9 (5.6–6.6) | 2.60 | 0.0094 |
TC (mmol/L) | 5.48 (4.93–6.14) | 5.33 (4.73–6.09) | 0.66 | 0.5063 |
HDL (mmol/L) | 1.55 (1.22–1.94) | 1.42 (1.18–1.76) | 1.88 | 0.0596 |
TG (mmol/L) | 1.56 (0.86–2.45) | 1.25 (0.84–2.17) | 0.82 | 0.4118 |
LDL (mmol/L) | 3.09 (2.23–3.57) | 3.12 (2.47–3.62) | 0.60 | 0.5466 |
DGLA (μmol/L) | 116.9 (97.2–146.8) | 108.6 (80.7–138.9) | 1.72 | 0.0862 |
EPA% | 1.45(0.9–2.3) | 1.80 (1.1–2.7) | 1.99 | 0.0469 |
DHA% | 3.8 (2.8–5.03) | 4.0 (3.1–5) | 0.82 | 0.4133 |
History of statin use | 9 (12.2%) | 28 (18.8%) | 1.64 | 0.2003 |
History of DL drugs | 8 (10.8%) | 32 (21.5%) | 4.10 | 0.0429 |
History of anti-HT drugs | 19 (25.7%) | 52 (34.9%) | 1.98 | 0.1595 |
History of diabetes drugs | 3 (4.1%) | 19 (12.8%) | 4.83 | 0.0280 |
NIHSS at admission | 9 (3–18) | 2 (1–5) | 6.03 | < 0.0001 |
NIHSS at discharge | 5 (1.5–12) | 1 (0–3) | 5.55 | < 0.0001 |
Hospitalization, days | 8 (8–9) | 8 (7–8) | 1.44 | 0.1497 |
In-hospital death, N | 2 (2.70%) | 1 (0.67%) | 1.42 | 0.2333 |